At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 242 enrolled
Drug / intervention
levofloxacin +2 moredrug
Likely dose
levofloxacin 750mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Double-Blind, Phase 3B Study to Compare the Safety and Clinical Efficacy of Levofloxacin in 750mg for 2 Weeks and Levofloxacin 750mg for 3 Weeks to That of Levofloxacin 500mg for 4 Weeks in the Treatment of Chronic Prostatitis
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.·interventional·Posted Nov 22, 2006·Updated Sep 13, 2013
In Brief
A Phase 3 clinical trial evaluating levofloxacin for Prostatitis. Completed, enrolled 242 participants across 39 sites.
Detailed Summary
The purpose of this study is to compare the safety and effectiveness of levofloxacin 750 mg for 2 weeks or 750 mg for 3 weeks, compared to levofloxacin 500 mg for 4 weeks in the treatment of chronic prostatitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstatitis
CountriesUnited States
CollaboratorsPriCara, Unit of Ortho-McNeil, Inc.
Timeline
Phase 3CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2006
First PostedNov 2006
Primary CompletionMar 2008
Study CompletionSep 2008
TodayJul 2026
First PostedNov 22, 2006
Enrollment StartNov 1, 2006
Primary CompletionMar 1, 2008
Study CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 19.6 years ago
Interventions
levofloxacindrug
750mg tablet once daily for 2 weeks followed by 2 weeks of placebo.
levofloxacindrug
750mg tablet once daily for 3 weeks followed by 1 week of placebo.
levofloxacindrug
500mg tablet once daily for 4 weeks.